Login / Signup

Improved adherence to statin treatment and differences in results between men and women after pictorial risk communication-a sub-study of the VIPVIZA RCT.

Henrik HolmbergEva-Lotta GladerUlf NäslundBo CarlbergEva SönnerstamMargareta NorbergAnders Själander
Published in: European journal of clinical pharmacology (2024)
The VIPVIZA study is registered with ClinicalTrials.gov , May 8, 2013, number NCT01849575.
Keyphrases
  • cardiovascular disease
  • coronary artery disease
  • type diabetes
  • adipose tissue
  • metabolic syndrome
  • skeletal muscle
  • combination therapy
  • low density lipoprotein